Cancer Significant Awareness Offered by Oncotarget

Oncotarget is a famous medical journal in the U.S that majorly talks about oncology aspects. The journal is usually peer-reviewed weekly. Oncotarget Journal was founded in 2010 and is published by Impact Journals. The editors in chief of the magazine are two talented media personalities, Mikhail Blagosklonny and Andrei V. Gudkov.Oncotarget has a goal of providing rapid publication of outstanding research. Today, tumors have become more complicated than before thereby the rate of resisting medication has increased. Oncotarget has therefore gone miles ahead to publish papers containing information on pathology, age-related diseases, endocrinology, immunology, neuroscience, autophagy, physiology, cell death, and chromosome. These topics are posted to educate everyone to a wider scope than just talking about tumors.

Scientists usually partner with the journal and to review and approve the surveys submitted by authors. Some rules are provided by Oncotarget to authors such as the text should be in Times New Roman style, 12pt font size and single spaced. The article should not have a past idea, and the manuscripts should be Microsoft Office, Open Document, WordPerfect or RTF. Moreover, articles submitted online must be less than 15 MBs and also the Heading should not be italicized unless it is a scientific name. For the correct format, an author is expected to use automated reference manager for the article. If an author does not follow these simple rules, the article will not be considered for reviewing its content.

Oncotarget management has many objectives to achieve as a journal. The journal aims at connecting different fields of biomedical science, to remove the bridge between specialties and to increase the benefits of their research by thorough reviewing. Moreover, Oncotarget aims at introducing the application of clinical and basic science and also at allowing significant surveys to be shared widely and quickly because of their great information.Also, Oncotarget has published 370 papers related to oxygen since 2010. Gregg L. Semenza and William G. Kaelin, two staff members of Oncotarget, won the Lasker Award for inventing an oxygen sensing pathway. Oncotarget has helped many people share out their knowledge on oncology. Mikhail Blagosklonny and other members hope Oncotarget will contribute to educating people on cancer until a permanent solution is found.

Comments are closed.